Literature DB >> 25817938

Inhibition of cytochrome P450 2B4 by environmentally persistent free radical-containing particulate matter.

James R Reed1, Albert Leo N dela Cruz2, Slawo M Lomnicki3, Wayne L Backes4.   

Abstract

Combustion processes generate particulate matter (PM) that can affect human health. The presence of redox-active metals and aromatic hydrocarbons in the post-combustion regions results in the formation of air-stable, environmentally persistent free radicals (EPFRs) on entrained particles. Exposure to EPFRs has been shown to negatively influence pulmonary and cardiovascular functions. Cytochromes P450 (P450/CYP) are endoplasmic reticulum resident proteins that are responsible for the metabolism of foreign compounds. Previously, it was shown that model EPFRs, generated by exposure of silica containing 5% copper oxide (CuO-Si) to either dicholorobenzene (DCB230) or 2-monochlorophenol (MCP230) at ≥ 230 °C, inhibited six forms of P450 in rat liver microsomes (Toxicol. Appl. Pharmacol. (2014) 277:200-209). In this study, the inhibition of P450 by MCP230 was examined in more detail by measuring its effect on the rate of metabolism of 7-ethoxy-4-trifluoromethylcoumarin (7EFC) and 7-benzyloxyresorufin (7BRF) by the purified, reconstituted CYP2B4 system. MCP230 inhibited the CYP2B4-mediated metabolism of 7EFC at least 10-fold more potently than non-EPFR controls (CuO-Si, silica, and silica generated from heating silica and MCP at 50 °C, so that EPFRs were not formed (MCP50)). The inhibition by EPFRs was specific for the P450 and did not affect the ability of the redox partner, P450 reductase (CPR) from reducing cytochrome c. All of the PM inhibited CYP2B4-mediated metabolism noncompetitively with respect to substrate. When CYP2B4-mediated metabolism of 7EFC was measured as a function of the CPR concentration, the mechanism of inhibition was competitive. EPFRs likely inhibit CYP2B4-mediated substrate metabolism by physically disrupting the CPR·P450 complex.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytochrome P450 2B4; Inhibition; Particulate matter, Environmentally persistent free radicals

Mesh:

Substances:

Year:  2015        PMID: 25817938      PMCID: PMC4406862          DOI: 10.1016/j.bcp.2015.03.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  49 in total

1.  Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution.

Authors:  David R Nelson
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

2.  Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs.

Authors:  Wolfgang G Kreyling; Manuela Semmler-Behnke; Jürgen Seitz; Wilfried Scymczak; Alexander Wenk; Paula Mayer; Shinji Takenaka; Günter Oberdörster
Journal:  Inhal Toxicol       Date:  2009-07       Impact factor: 2.724

3.  Role of free radicals in the toxicity of airborne fine particulate matter.

Authors:  B Dellinger; W A Pryor; R Cueto; G L Squadrito; V Hegde; W A Deutsch
Journal:  Chem Res Toxicol       Date:  2001-10       Impact factor: 3.739

Review 4.  Oxygen activation by cytochrome P-450.

Authors:  R E White; M J Coon
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.

Authors:  D R Dutton; A Parkinson
Journal:  Arch Biochem Biophys       Date:  1989-02-01       Impact factor: 4.013

6.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

Authors:  C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

7.  Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms.

Authors:  Emilija Makaji; Cristina S Trambitas; Pamela Shen; Alison C Holloway; Denis J Crankshaw
Journal:  Toxicol Sci       Date:  2009-10-25       Impact factor: 4.849

8.  Environmentally persistent free radicals decrease cardiac function and increase pulmonary artery pressure.

Authors:  Sarah Mahne; Gin C Chuang; Edward Pankey; Lucy Kiruri; Philip J Kadowitz; Barry Dellinger; Kurt J Varner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-31       Impact factor: 4.733

Review 9.  Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.

Authors:  Günter Oberdörster; Eva Oberdörster; Jan Oberdörster
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

10.  Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection.

Authors:  Greg I Lee; Jordy Saravia; Dahui You; Bishwas Shrestha; Sridhar Jaligama; Valerie Y Hebert; Tammy R Dugas; Stephania A Cormier
Journal:  Part Fibre Toxicol       Date:  2014-10-30       Impact factor: 9.400

View more
  3 in total

1.  Formation of environmentally persistent free radicals (EPFRs) on ZnO at room temperature: Implications for the fundamental model of EPFR generation.

Authors:  Matthew C Patterson; Mark F DiTusa; Cheri A McFerrin; R L Kurtz; Randall W Hall; E D Poliakoff; P T Sprunger
Journal:  Chem Phys Lett       Date:  2016-12-31       Impact factor: 2.328

2.  Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.

Authors:  James R Reed; Albert Leo N dela Cruz; Slawo M Lomnicki; Wayne L Backes
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-28       Impact factor: 4.219

Review 3.  The functional effects of physical interactions involving cytochromes P450: putative mechanisms of action and the extent of these effects in biological membranes.

Authors:  James R Reed; Wayne L Backes
Journal:  Drug Metab Rev       Date:  2016-08       Impact factor: 4.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.